3 most recent filings and news items mentioning STTK. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/STTK/news?limit=20"
Pull STTK filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayShattuck Labs is conducting an underwritten public offering of 10.9 million common shares and 7.9 million pre-funded warrants with representatives including Leerink Partners, J.P. Morgan Securities, Piper Sandler, and Cantor Fitzgerald. The offering is expected to raise capital f
View filing at SEC.gov →Shattuck Labs reported Phase 1 data for SL-325 showing a potentially best-in-mechanism immunogenicity profile with only 3.7% antidrug antibodies and complete TL1A blockade lasting over 3 months. The company plans to initiate Phase 2b trials in Crohn's disease in Q3 2026, advancin
View filing at SEC.gov →Shattuck Labs adopted an amended and restated 2020 Equity Incentive Plan, succeeding the prior 2016 plan with enhanced award provisions for employees, directors and consultants. The update reflects standard corporate governance practices to maintain competitive compensation struc
View filing at SEC.gov →